Soliton (NASDAQ:SOLY) Now Covered by Maxim Group
Maxim Group started coverage on shares of Soliton (NASDAQ:SOLY) in a research note released on Thursday morning, Briefing.com Automated Import reports. The brokerage issued a buy rating and a $22.00 price objective on the stock.
Separately, ValuEngine lowered shares of Soliton from a buy rating to a hold rating in a report on Tuesday, October 1st.
SOLY stock opened at $10.89 on Thursday. The firm’s 50-day moving average price is $11.49 and its two-hundred day moving average price is $12.70. Soliton has a 12-month low of $4.12 and a 12-month high of $29.00.
Soliton Company Profile
Soliton, Inc, an early stage medical device company, focuses on developing and commercializing products using a proprietary rapid acoustic pulse technology platform. It offers a device for the removal of tattoos. The company was founded in 2012 and is headquartered in Houston, Texas.
See Also: What is the operating income formula?
Receive News & Ratings for Soliton Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Soliton and related companies with MarketBeat.com's FREE daily email newsletter.